Position in AZN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,513,006,423
+$1,512,263,299 QoQ
Shares Held
7,979,150
+211660.9% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
5.81%
of 13F equity value
Holder Rank
#27
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rathbones Group PLC holds $2,298,575,113 across 12 Drug Manufacturers - General names. AZN ranks #1 (65.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
7,979,150 | $1,513,006,423 | |
| 2 | LLY |
ELI LILLY & Co
|
447,654 | $536,929,681 | |
| 3 | JNJ |
Johnson & Johnson
|
691,961 | $175,737,335 | |
| 4 | MRK |
Merck & Co., Inc.
|
207,542 | $26,669,147 | |
| 5 | ABBV |
AbbVie Inc.
|
65,288 | $16,429,072 | |
| 6 | PFE |
Pfizer Inc
|
433,531 | $10,439,426 | |
| 7 | AMGN |
Amgen Inc
|
20,628 | $7,469,811 | |
| 8 | NVS |
Novartis AG
|
43,692 | $6,847,410 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,513,006,423 | 7,979,150 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $743,124 | 3,768 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||